Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Strana 1 z 132 Výsledek
Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to the cancerology field. More particularly, the subject of the present invention is a method for the in vitro diagnosis of colorectal cancer in a human patient, by determining the presence of protein disulfide isomerase (PDI) in a biological sample taken from this
Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to the cancerology field. More particularly, the subject of the present invention is a method for the in vitro diagnosis of colorectal cancer in a human patient, by determining the presence of protein disulfide isomerase (PDI) in a biological sample taken from this
Method of treating cancer using tetraethyl thiuram disulfide
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention generally relates to methods of treating cancer, and particularly to methods of treating cancer using dithiocarbamate.
BACKGROUND OF THE INVENTION
Cancer, the uncontrolled growth of malignant cells, is a major health problem of the modern medical era and ranks
Colon tumor specific binding peptides
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Colon carcinogenesis is thought to be a stepwise process that involves the transition of normal colon epithelium to neoplasm. The multistep progression of the disease requires years and possibly decades, and therefore apparently provides ample time for diagnosis and
Anti-bFGF humanized double-stranded antibody with stable disulfide bond, preparation method and application thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2012/080357 filed on Aug. 20, 2012, published in Chinese, which claims the benefit of China Patent Application No. 201110450855.0 filed Dec. 28,
Disulfide-linked multivalent MHC class I comprising multi-function proteins
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 371 of PCT International Application No. PCT/EP2013/077109, filed on Dec. 18, 2013, currently pending, the contents of which are incorporated by reference in its entirety, and which claims priority to European Application No.
Tethering cysteine residues using cyclic disulfides
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Many therapeutic molecules form covalent bonds with cysteine residues on their protein targets. The mechanisms of the majority of these molecules were either elucidated long after development or are not fully understood. Recent successful drug discovery efforts, however,
Amino disulfides
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present invention refers to mitomycin analogs containing a disulfide group (Class 260 Subclass 326.24). These compounds are mitomycin C derivatives in which the 7-amino group bears an organic substituent incorporating a disulfide group. These compounds are inhibitors of
Diphenyl disulfide compounds
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
This invention relates to novel diphenyl disulfide compounds having the activities to inhibit the production of Interleukin-1.beta. (IL-1.beta.) and the release of Tumor Necrosis Factor.alpha. (TNF.alpha.).
BACKGROUND OF THE INVENTION
IL-1.beta. is a protein produced mainly
Amino disulfide thiol exchange products
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present compounds are mitomycin C analogs (Class 548, Subclass 422) in which the 7-amino group is substituted by a disulfide containing organic group. These compounds are inhibitors of experimental animal tumors.
BACKGROUND OF THE INVENTION
Nomenclature--The systematic
Protein particles comprising disulfide crosslinkers and uses
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED AS A TEXT FILE VIA THE OFFICE ELECTRONIC FILING SYSTEM (EFS-WEB)
The Sequence Listing associated with this application is provided in text format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the
Protein particles comprising disulfide crosslinkers and uses related thereto
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED AS A TEXT FILE VIA THE OFFICE ELECTRONIC FILING SYSTEM (EFS-WEB)
The Sequence Listing associated with this application is provided in text format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the
Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD
The invention relates to a biodegradable polymer material and its application, in particular to a carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and its application, belonging to the field of medical material.
BACKGROUND
Liver cancer biomarkers
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present invention concerns methods of screening for or detecting liver cancer in subjects, including subjects with or without previously detected risk factors for liver cancer.
BACKGROUND OF THE INVENTION
Hepatocellular carcinoma (HCC), the major histological form of
Polymer/copper combination for targeted cancer therapy
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND
Although various anticancer drugs have been developed in an attempt to conquer cancer, a large number of cancer patients ultimately still lose their battle. There are two major causes for this failure: inherited or acquired drug resistance by the cancer cells and side effects due to the
Nejúplnější databáze léčivých bylin podložená vědou
- Funguje v 55 jazycích
- Bylinné léky podporované vědou
- Rozpoznávání bylin podle obrázku
- Interaktivní mapa GPS - označte byliny na místě (již brzy)
- Přečtěte si vědecké publikace související s vaším hledáním
- Hledejte léčivé byliny podle jejich účinků
- Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty
Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu
